TransMolecular explained

TransMolecular, Inc.
Industry:	Biotech
Hq Location City:	Birmingham, Alabama
Parent:	Morphotek, Inc. (from 2011)

TransMolecular was a biotech company located in Birmingham, Alabama. It was geared to finding anti-cancer targeted drugs.^[1]

TransMolecular, Inc. engaged in discovering, developing, and commercializing therapies for glioma, metastatic brain tumors, and cancers. It developed TM601, a synthetically-produced polypeptide that was derived from scorpion venom, which is used to specifically target tumors in the treatment of cancer.^[2] The company was founded in 1996. In 2003, Fortune Magazine listed the company as one of the 14 "most exciting, innovative companies in the nation".^{[3] [4]}

In March 2011, TransMolecular's assets were purchased by Morphotek, a subsidiary of the Japanese pharmaceutical company Eisai.^[5]

References

1. News: Hope for brain cancer cure . McIntosh . Charlotte . Birmingham Post-Herald . 23 Oct 2000 . B1.
2. News: Scorpion sting may be cure for brain cancer . Kowalczyk . Liz . 30 Jan 1999 . 4B . The Anniston Star . Anniston, Alabama.
3. News: Technology incubator . Centers . Jessica . The Anniston Star . Anniston, Alabama . 15 Mar 2004 . 1B.
4. Web site: 14 Hot Startups . CNN Money . 1 Feb 2003 . Keeney . Jennifer . Kwon . Beth . Overfelt . Maggie . 21 December 2023.
5. Web site: Morphotek Acquires TransMolecular's Tumor-Targeting Drug Delivery Assets . Genetic Engineering & Biotechnology News . 5 April 2011 . 21 December 2023.